FDA approves GSK's Hibsago for chronic hepatitis B treatment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.27 +1.25 (2.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.02 | 52 Week High | $45.58 | |||
| Open | $50.29 | 52 Week Low | $37.82 | |||
| Day High | $51.42 | P/E | N/A | |||
| Day Low | $49.97 | EPS | $0.00 | |||
| Volume | 2,744,010 | |||||
